INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 230 filers reported holding INARI MED INC in Q2 2022. The put-call ratio across all filers is 2.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $81,744 | +3.4% | 1,249,894 | -8.1% | 0.01% | +9.1% |
| Q2 2023 | $79,033 | -31.3% | 1,359,337 | -27.1% | 0.01% | -35.3% |
| Q1 2023 | $115,073 | +125.5% | 1,863,816 | +132.1% | 0.02% | +112.5% |
| Q4 2022 | $51,037 | -99.9% | 802,977 | +21.1% | 0.01% | 0.0% |
| Q3 2022 | $48,164,000 | -64.0% | 663,048 | -66.3% | 0.01% | -52.9% |
| Q2 2022 | $133,689,000 | -8.4% | 1,966,302 | +22.1% | 0.02% | +13.3% |
| Q1 2022 | $145,930,000 | +42.9% | 1,609,993 | +43.8% | 0.02% | +66.7% |
| Q4 2021 | $102,156,000 | +43.4% | 1,119,275 | +27.5% | 0.01% | +28.6% |
| Q3 2021 | $71,219,000 | +152.2% | 878,163 | +190.0% | 0.01% | +133.3% |
| Q2 2021 | $28,242,000 | -53.8% | 302,766 | -47.1% | 0.00% | -50.0% |
| Q1 2021 | $61,193,000 | +19.5% | 571,894 | -2.5% | 0.01% | +20.0% |
| Q4 2020 | $51,192,000 | +26.0% | 586,456 | -0.4% | 0.01% | 0.0% |
| Q3 2020 | $40,643,000 | +26.4% | 588,859 | -11.3% | 0.01% | +25.0% |
| Q2 2020 | $32,151,000 | – | 663,734 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darsana Capital Partners LP | 1,475,000 | $137,588,000 | 3.91% |
| Affinity Asset Advisors, LLC | 85,000 | $7,929,000 | 2.84% |
| Parian Global Management LP | 49,800 | $4,645,000 | 1.99% |
| AlpInvest Partners B.V. | 27,960 | $2,608,000 | 1.28% |
| Sio Capital Management, LLC | 46,332 | $4,322,000 | 1.07% |
| HARBOURVEST PARTNERS LLC | 88,598 | $8,264,000 | 0.79% |
| HAMILTON LANE ADVISORS LLC | 26,403 | $2,463,000 | 0.77% |
| Pier Capital, LLC | 76,708 | $7,155,000 | 0.72% |
| Lisanti Capital Growth, LLC | 46,035 | $4,294,000 | 0.53% |
| NEXT CENTURY GROWTH INVESTORS LLC | 66,822 | $6,233,000 | 0.49% |